A graduate of Eastern Washington University with a degree in Biochemistry - Biotechnology, Scott brings over 20 years of expertise in the biotechnology industry. Beginning at the Fred Hutchinson Cancer Research Center, Scott specialized in nephrology research before moving on to AMGEN IMMUNEX. At AMGEN, he focused on the purification and formulation of biologics and protein reagents, developing large-scale IgG2 purification processes and contributing to the advancement of small molecule enzymology.

Scott has extensive experience in process development, particularly in the separation and purification of non-tagged biologics for early therapeutic studies. His work has been crucial in ensuring high-quality biologic products, with a focus on minimizing contaminants. With a deep understanding of biologics and a commitment to innovation, Scott leads the company with a focus on excellence in product development.